期刊文献+

新药研发外包中的风险控制 被引量:3

Risk control of the new drug R&D outsourcing
下载PDF
导出
摘要 目的探讨如何控制新药研发外包中可能出现的风险。方法主要分析了新药研发外包各阶段可能存在主要的风险及危害。结果与结论有针对性地采取风险控制措施:如建立科学的外包服务商选择评估体系;制定严谨、灵活的合作合同;建立利益共享、风险共担机制;建立有效的信息反馈、绩效测评机制等。都将有效实现对研发外包潜在风险的控制,使企业研发外包收益最大化。 Objective To discuss howto control the potential risks in the RD outsourcing of the newdrugs.Methods Potential risks and its danger in the RD outsourcing of the newdrugs in different phase were analyzed. Results and Conclusion The risk control methods should be put into use targetedly,such as bringing in outsourcing service providers' competitive mechanism,enacting flexible cooperating compact,establishing benefit and risk sharing mechanism,setting up effective information feedback and performance evaluation mechanism and so on. All these methods can control the potential risks in the RD outsourcing effectively,and maximize the profits of the enterprises' RD outsourcing.
作者 佟笑 陈玉文
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2015年第11期887-891,共5页 Journal of Shenyang Pharmaceutical University
基金 科技部"十二五"重大新药创制国家科技重大专项"辽宁省国家重大新药创制综合平台―基于信息管理的新药研发风险控制技术"(2013ZX09301305)
关键词 风险管理 研发外包 运用 探讨 risk management R&D outsourcing application research
  • 相关文献

参考文献6

二级参考文献23

  • 1曼鹿.新药研发,借力CRO[J].医药世界,2005(6):56-57. 被引量:9
  • 2金泉源,连桂玉,黄泰康.新药研发技术风险及其应对策略研究[J].中国药业,2006,15(15):14-15. 被引量:12
  • 3Zaheer A, MeEvlly B, Perron V. Does Trust Matter? Exploring the effect of interorganizational and Interpersonal Trust on Performance[J]. Organizat Sci, 1998,9: 114-159.
  • 4Lacetera N. Different missions and commitment power in R&D organizations, theory and evidence on industry - u- niversity Alliances [ J 1. Organization Science, 2009, 20(3) : 565 -582.
  • 5加里·P.皮萨诺.生物制药技术[A].本·斯泰尔,戴维·维克托,理查德·内尔森.技术创新与经济绩效[C].上海:上海人民出版社,2006.
  • 6Lerner J, Malmendier U. Contractibility and the design of research agreements [ R ]. NBER Working Paper, No. 11292, 2005.
  • 7Lerner J, Malmendier U. Contractibility and the design of research agreements [ J]. American Economic Re- view, 2010, 100(1) : 214 -246.
  • 8Robinson D T, Stuart T E. Financial contracting in bio-tech strategic alliances [ J ]. Journal of Law and Eco- nomics, 2007, 50(3): 559-595.
  • 9Pharmaceutical Research and Manufacturers or America. Drug Discovery and Development: Understanding the R&D Process[ EB/OL]. www. innovation, org, Febru- ary 2007.
  • 10Comino S, Nicolo S, Tedeschi A. Termination clauses in partnerships [ J ]. European Economic Review, 2010, 54(5) : 718 -732.

共引文献19

同被引文献47

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部